Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Molecular Characterization and Mortality From Breast Cancer in Men.

Massarweh SA, Sledge GW, Miller DP, McCullough D, Petkov VI, Shak S.

J Clin Oncol. 2018 May 10;36(14):1396-1404. doi: 10.1200/JCO.2017.76.8861. Epub 2018 Mar 27.

2.

Endocrine therapy and strategies to overcome therapeutic resistance in breast cancer.

Mancuso MR, Massarweh SA.

Curr Probl Cancer. 2016 Mar - Aug;40(2-4):95-105. doi: 10.1016/j.currproblcancer.2016.09.001. Epub 2016 Sep 17. Review.

PMID:
27839747
3.

Special considerations in the evaluation and management of breast cancer in men.

Massarweh SA, Choi GL.

Curr Probl Cancer. 2016 Mar - Aug;40(2-4):163-171. doi: 10.1016/j.currproblcancer.2016.09.003. Epub 2016 Sep 17. Review.

PMID:
27793424
4.

Introduction to special issue on breast cancer.

Massarweh SA.

Curr Probl Cancer. 2016 Mar - Aug;40(2-4):93-94. doi: 10.1016/j.currproblcancer.2016.09.010. Epub 2016 Sep 23. No abstract available.

PMID:
27793423
5.

Advanced concepts in estrogen receptor biology and breast cancer endocrine resistance: implicated role of growth factor signaling and estrogen receptor coregulators.

Schiff R, Massarweh SA, Shou J, Bharwani L, Arpino G, Rimawi M, Osborne CK.

Cancer Chemother Pharmacol. 2005 Nov;56 Suppl 1:10-20. Review.

PMID:
16273359
6.

Cross-talk between estrogen receptor and growth factor pathways as a molecular target for overcoming endocrine resistance.

Schiff R, Massarweh SA, Shou J, Bharwani L, Mohsin SK, Osborne CK.

Clin Cancer Res. 2004 Jan 1;10(1 Pt 2):331S-6S.

Supplemental Content

Loading ...
Support Center